The Effect of Group Cognitive-Behavioral Therapy on Mood Symptoms and Substance Cravings in Men with Bipolar Disorder and Substance Use Disorder: A Randomized Controlled Trial

Document Type : Original Article

Authors

1 Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran

2 Chronic Diseases (Home Care) Research Center, Institute of Cancer, Hamadan University of Medical Sciences, Hamadan, Iran

3 Department of Nursing, School of Malayer Medical Sciences, Hamadan University of Medical Sciences, Hamadan, Iran

4 Cancer Research Center, Institute of Cancer, Hamadan University of Medical Sciences, Hamadan, Iran

5 Department of Nursing, School of Nursing and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran

10.22122/ahj.2026.200691.1646

Abstract

Background: Many patients with bipolar disorder also experience substance use disorder, along with frequent mood swings and substance cravings. It appears that traditional medication treatments may not be sufficient for these individuals. This study sought to examine how cognitive-behavioral group therapy could impact mood symptoms and substance cravings in male patients dealing with both bipolar disorder and substance abuse.
Methods: A randomized controlled clinical trial was conducted in the psychiatric departments of Sina Educational and Medical Center in Hamadan in 2023. Forty individuals were allocated to two distinct groups. The intervention group participated in eight sessions of group cognitive-behavioral therapy. Data were collected using a demographic questionnaire, the Hirschfeld Mood Disorder questionnaire, the Beck Depression Inventory, and the Craving Beliefs Questionnaire. The data were analyzed using SPSS 22.
Findings: Prior to the intervention, there were no significant differences between the intervention and control groups (P > 0.05). Following the intervention, both groups experienced a decrease in mood symptoms and craving, with the intervention group showing a significantly greater reduction (P < 0.001). However, one and three months after discharge, the patients in both groups experienced a gradual recurrence of mood symptoms and cravings. Despite this, patients in the intervention group consistently showed better outcomes than the control group at each time point (P < 0.001).
Conclusion: The intervention group successfully managed mood symptoms and substance cravings in bipolar patients with a history of substance dependence. This non-pharmacological method is recommended for initial use as part of a comprehensive treatment course, followed by incorporation as an intermittent maintenance strategy.

Keywords

References

  1. Carvalho AF, Firth J, Vieta E. Bipolar Disorder. N Engl J Med. 2020;383(1):58–66. doi:10.1056/NEJMra1906193
  2. Rowland TA, Marwaha S. Epidemiology and risk factors for bipolar disorder. Ther Adv Psychopharmacol. 2018;8(9):251– 69. doi:10.1177/2045125318769235
  3. Mohammadi MR, Davidian H, Noorbala AA, Malekafzali H, Naghavi HR, Pouretemad HR, et al. An epidemiological survey of psychiatric disorders in Iran. Clin Pract Epidemiol Ment Health. 2005;1:16. doi:10.1186/1745-0179-1-16
  4. Jeste PDV, Lieberman PEJA, Fassler TD, Peele SR. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric; 2013. doi:10.1176/appi. books.9780890425596
  5. Dembek C, Mackie D, Modi K, Zhu Y, Niu X, Grinnell T. The economic and humanistic burden of bipolar disorder in adults in the United States. Ann Gen Psychiatry. 2023;22(1):13. doi:10.1186/s12991-023-00440-7
  6. Canham SL, Mahmood A, Stalman MN, King D, O’Rourke N. Personal theories of substance use among middle-aged and older adults with bipolar disorder. Aging Ment Health. 2018;22(6):813–8. doi:10.1080/13607863.2017.1299689
  7. Preuss UW, Schaefer M, Born C, Grunze H. Bipolar Disorder and Comorbid Use of Illicit Substances. Medicina (Kaunas). 2021;57(11). doi:10.3390/medicina57111256
  8. Kenneson A, Funderburk JS, Maisto SA. Substance use disorders increase the odds of subsequent mood disorders. Drug Alcohol Depend. 2013;133(2):338–43. doi:10.1016/j. drugalcdep.2013.06.011
  9. Lieberman DZ, Kolodner G, Massey SH, Williams KP. Antidepressant-induced mania with concomitant mood stabilizer in patients with comorbid substance abuse and bipolar disorder. J Addict Dis. 2009;28(4):348–55. doi:10.1080/10550880903182994
  10. Cavicchioli M, Vassena G, Movalli M, Maffei C. Is craving a risk factor for substance use among treatment-seeking individuals with alcohol and other drugs use disorders? A meta-analytic review. Drug Alcohol Depend. 2020;212:108002. doi:10.1016/j.drugalcdep.2020.108002
  11. Waters AJ, Schoenmakers TM, Snelleman M, Szeto EH, Franken IHA, Hendriks VM, et al. Affect, motivation, temptation, and drinking among alcohol-dependent outpatients trying to maintain abstinence: An Ecological Momentary Assessment study. Drug Alcohol Depend. 2020;206:107626. doi:10.1016/j.drugalcdep.2019.107626
  12. Substance A, Mental Health Services A. CBHSQ Methodology Report. Impact of the DSM-IV to DSM-5 Changes on the National Survey on Drug Use and Health. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2016.
  13. Magill M, Ray L, Kiluk B, Hoadley A, Bernstein M, Tonigan JS, et al. A meta-analysis of cognitive-behavioral therapy for alcohol or other drug use disorders: Treatment efficacy by contrast condition. J Consult Clin Psychol. 2019;87(12):1093– 105. doi:10.1037/ccp0000447
  14. Beck AT. Cognitive therapy and the emotional disorders. 2 ed. New York, NY: International Universities Press; 1976.
  15. Robertson D. The philosophy of cognitive-behavioural therapy (CBT): Stoic philosophy as rational and cognitive psychotherapy. 2st edition ed. US: Routledge; 2020.
  16. Gregory VL, Jr., Ellis RJB. Cognitive-behavioral therapy and buprenorphine for opioid use disorder: A systematic review and meta-analysis of randomized controlled trials. Am J Drug Alcohol Abuse. 2020;46(5):520–30. doi:10.1080/00952990. 2020.1780602
  17. Severe J, Pfeiffer PN, Palm-Cruz K, Hoeft T, Sripada R, Hawrilenko M, et al. Clinical Predictors of Engagement in Teleintegrated Care and Telereferral Care for Complex Psychiatric Disorders in Primary Care: a Randomized Trial. J Gen Intern Med. 2022;37(13):3361–7. doi:10.1007/s11606- 021-07343-x
  18. Arman S, Golmohammadi F, Maracy M, Molaeinezhad M. Efficacy of Group Cognitive-behavioral Therapy in Maintenance Treatment and Relapse Prevention for Bipolar Adolescents. Adv Biomed Res. 2018;7:41. doi:10.4103/abr. abr_168_16
  19. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543–52. doi:10.1001/archpsyc.64.5.543
  20. Haghighat S, Mohammadi A. Comparison of the Effectiveness of Cognitive Behavioral Therapy and Acceptance and Commitment Therapy on Reducing Mood Symptoms in Patients With Substance Abuse. International Clinical Neuroscience Journal. 2018;5:158–63. doi:10.15171/ icnj.2018.28
  21. Yoshinaga N, Nosaki A, Hayashi Y, Tanoue H, Shimizu E, Kunikata H, et al. Cognitive Behavioral Therapy in Psychiatric Nursing in Japan. Nurs Res Pract. 2015;2015:529107. doi:10.1155/2015/529107
  22. Hirschfeld RM, Williams JB, Spitzer RL, Calabrese JR, Flynn L, Keck PE, Jr., et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157(11):1873–5. doi:10.1176/appi.ajp.157.11.1873
  23. Barekatain M, Maracy M R, Kheirabadi G R. A Study of Factor Structure of the Mood Disorder Questionnaire in a Sample of Iranian Pregnant Women.Iran J Psychiatry Behav Sci.2008;2(2):30-34.
  24. Beck AT, Beck RW. Screening depressed patients in family practice. A rapid technic. Postgrad Med. 1972;52(6):81–5. do i:10.1080/00325481.1972.11713319
  25. Aalto AM, Elovainio M, Kivimäki M, Uutela A, Pirkola S. The Beck Depression Inventory and General Health Questionnaire as measures of depression in the general population: a validation study using the Composite International Diagnostic Interview as the gold standard. Psychiatry Res. 2012;197(1- 2):163–71. doi:10.1016/j.psychres.2011.09.008
  26. Ariapooran S, Ahadi B, Khezeli M. Depression, anxiety, and suicidal ideation in nurses with and without symptoms of secondary traumatic stress during the COVID-19 outbreak. Arch Psychiatr Nurs. 2022;37:76–81. doi:10.1016/j. apnu.2021.05.005
  27. Dadfar M, Kalibatseva Z. Psychometric Properties of the Persian Version of the Short Beck Depression Inventory with Iranian Psychiatric Outpatients. Scientifica (Cairo). 2016;2016:8196463. doi:10.1155/2016/8196463
  28. Wright FD. Craving Beliefs Questionnaire. In: Beck AT, Wright FD, Newman CF, Liese BS, editors. Cognitive Therapy of Substance Abuse. New York: Guilford Press; 1993.
  29. Chang CW, Huang CW, Wu WH, Wang BE, Liu YL, Shen HC, et al. Psychometric properties of the Chinese craving beliefs questionnaire for heroin abusers in methadone treatment. BMC Psychiatry. 2011;11:39. doi:10.1186/1471-244x-11-39
  30. Mohammadkhani S, Sadeghi N, Farzad V. The causal model of relationships of negative emotions, core beliefs, substance-related beliefs, craving and emotion regulation with substance abuse relapse. Journal of Modern Psychological Researches. 2011;6(23):155–81.
  31. Özdel K, Kart A, Türkçapar MH. Cognitive Behavioral Therapy in Treatment of Bipolar Disorder. Noro Psikiyatr Ars. 2021;58(Suppl 1):S66–s76. doi:10.29399/npa.27419
  32. Ye BY, Jiang ZY, Li X, Cao B, Cao LP, Lin Y, et al. Effectiveness of cognitive behavioral therapy in treating bipolar disorder: An updated meta-analysis with randomized controlled trials. Psychiatry Clin Neurosci. 2016;70(8):351–61. doi:10.1111/ pcn.12399
  33. Belete H, Ali T, Legas G. Relapse and Clinical Characteristics of Patients with Bipolar Disorders in Central Ethiopia: A Cross-Sectional Study. Psychiatry J. 2020;2020:8986014. doi:10.1155/2020/8986014
  34. Watkins KE, Hunter SB, Hepner KA, Paddock SM, de la Cruz E, Zhou AJ, et al. An effectiveness trial of group cognitive behavioral therapy for patients with persistent depressive symptoms in substance abuse treatment. Arch Gen Psychiatry. 2011;68(6):577–84. doi:10.1001/archgenpsychiatry.2011.53
  35. Chiang KJ, Tsai JC, Liu D, Lin CH, Chiu HL, Chou KR. Efficacy of cognitive-behavioral therapy in patients with bipolar disorder: A meta-analysis of randomized controlled trials. PLoS One. 2017;12(5):e0176849. doi:10.1371/journal. pone.0176849
  36. Boschloo L, Bekhuis E, Weitz ES, Reijnders M, DeRubeis RJ, Dimidjian S, et al. The symptom-specific efficacy of antidepressant medication vs. cognitive behavioral therapy in the treatment of depression: results from an individual patient data meta-analysis. World Psychiatry. 2019;18(2):183–91. doi:10.1002/wps.20630
  37. Weitz ES, Hollon SD, Twisk J, van Straten A, Huibers MJ, David D, et al. Baseline Depression Severity as Moderator of Depression Outcomes Between Cognitive Behavioral Therapy vs Pharmacotherapy: An Individual Patient Data Meta-analysis. JAMA Psychiatry. 2015;72(11):1102–9. doi:10.1001/ jamapsychiatry.2015.1516
  38. Shahzadi M, Abbas Q. Individualised cognitive behaviour therapy in patients of substance use disorders: three case studies. J Pak Med Assoc. 2020;70(9):1657–60. doi:10.5455/ jpma.38839
  39. Trick L, Butler K, Bourgault Z, Vandervoort J, Le Foll B. Implementation and Preliminary Evaluation of a 12-Week Cognitive Behavioural and Motivational Enhancement Group Therapy for Cannabis Use Disorder. Subst Abuse. 2023;17:11782218231205840. doi:10.1177/11782218231205840
Addiction & Health
Volume 18
Pages 1-10

Files

Share

How to cite

Statistics